Sponsored by:

Molecular Imaging: Page 288

ImaginAb inks deal with MacroGenics
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb has entered into a collaboration and commercialization agreement with MacroGenics to develop an anti-CD3 clinical imaging product, for which MacroGenics may receive future milestones and royalties.
September 9, 2012
Eckert & Ziegler to acquire Vitalea Science
By AuntMinnie.com staff writers
Eckert & Ziegler's Californian subsidiary, Eckert & Ziegler Isotope Products, has signed an agreement to purchase of all of Vitalea Science's stock and assets.
September 9, 2012
IBA Molecular creates 2 centers of excellence
By AuntMinnie.com staff writers
Radiopharmaceutical provider IBA Molecular has created two centers for innovation designed for advanced radiopharmaceutical contract development and manufacturing.
September 9, 2012
FDA calls out Lilly on Amyvid images
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration is admonishing Eli Lilly for posting what it called "misleading" multicolored images on its website illustrating results with the PET radiopharmaceutical Amyvid (florbetapir F-18 injection).
September 9, 2012
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
September 9, 2012
Bracco short on CardioGen PET generators
By AuntMinnie.com staff writers
In an August 20 communiqué to its customers, Bracco Diagnostics acknowledged there is a "small number" of CardioGen-82 rubidium generators available, as the company continues its phased reintroduction of the imaging agent to the market.
September 6, 2012
Mediso debuts new preclinical platform
By AuntMinnie.com staff writers
Mediso Medical Imaging Systems has launched its new nanoScan four-modality preclinical imaging platform.
September 6, 2012
DraxImage, Positron to boost radiopharma supply
By AuntMinnie.com staff writers
Canadian radiopharmaceutical firm Jubilant DraxImage (JDI) said it is teaming with PET vendor Positron to increase the sourcing and supply of strontium-82 and rubidium-82 generators.
September 6, 2012
Nordion posts mixed Q3, 9-month results
By AuntMinnie.com staff writers
Nordion posted mixed results for its third-quarter and nine-month revenues for fiscal 2012.
September 5, 2012
NIH awards grant for PET/CT standardization
By AuntMinnie.com staff writers
The U.S. National Institutes of Health's (NIH) National Cancer Institute has awarded a five-year research project grant to the Universities of Iowa, Pennsylvania, and Washington to identify harmonized PET/CT reconstruction parameters for use in clinical trials, according to the Society of Nuclear Medicine and Molecular Imaging.
September 5, 2012
FDG-PET/CT may predict breast cancer outcome
By AuntMinnie.com staff writers
FDG-PET/CT can help predict disease-free survival for patients with invasive ductal breast cancer, according to a study published in the September issue of the Journal of Nuclear Medicine.
September 4, 2012
Navidea taps new CMO
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals announced it has appointed a new chief medical officer (CMO).
September 4, 2012
Previous Page
Page 288 of 611
Next Page